Prescription drug · ANDA
Glyburide NDC 71335-2771
Glyburide 5 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2771-1 | 71335277101 | 30 TABLET in 1 BOTTLE (71335-2771-1)Marketed from Oct 3, 2025 | |
| 71335-2771-2 | 71335277102 | 120 TABLET in 1 BOTTLE (71335-2771-2)Marketed from Oct 3, 2025 | |
| 71335-2771-3 | 71335277103 | 100 TABLET in 1 BOTTLE (71335-2771-3)Marketed from Oct 3, 2025 | |
| 71335-2771-4 | 71335277104 | 60 TABLET in 1 BOTTLE (71335-2771-4)Marketed from Oct 3, 2025 | |
| 71335-2771-5 | 71335277105 | 90 TABLET in 1 BOTTLE (71335-2771-5)Marketed from Oct 3, 2025 | |
| 71335-2771-6 | 71335277106 | 180 TABLET in 1 BOTTLE (71335-2771-6)Marketed from Oct 3, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glyburide
- Generic name (nonproprietary)
- glyburide
- Active ingredients
- Glyburide — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203379
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 71335-2771_ce71c7bb-a31a-4b76-8d0c-d717e8eeda9bSPL ID ce71c7bb-a31a-4b76-8d0c-d717e8eeda9bSPL set ID db074991-1267-454a-8b1d-b6f52e2132ccRxCUI 310537UNII SX6K58TVWC
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335277101followed by a unit qualifier and the quantityPackage 71335-2771-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Glyburide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203379
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glyburide | Glyburide 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7859 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8508 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7408 |
| Glyburide | Glyburide 1.25 mg/1 | TabletOral | Cadila Pharmaceuticals Limited | 71209-009 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | Cadila Pharmaceuticals Limited | 71209-010 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | Cadila Pharmaceuticals Limited | 71209-011 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4035 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3452 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3504 |
| Glyburide | Glyburide 1.25 mg/1 | TabletOral | Modavar Pharmaceuticals LLC | 72241-038 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-6196 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | Modavar Pharmaceuticals LLC | 72241-039 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | Modavar Pharmaceuticals LLC | 72241-040 |